Des-γ-carboxy prothrombin (DCP), known as antagonist-II (PIVKA-II), is a vital serum biomarker for the clinical screening of HCC, emanating from HCC cells in conditions of vitamin K insufficiency or defects in gamma-carboxylase enzyme [17, 18]. Here, ACE is linked to hepatocellular carcinoma.